pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·21h ago·1 min read
save

TGA opens consultation on temporary rise in Australian medical device annual fees

Oct 26, 2026·read at raps ↗RegulatoryNeutral

The Therapeutic Goods Administration (TGA) in Australia announced a public consultation regarding a proposed temporary increase to the annual charges that medical device manufacturers must pay.

The consultation seeks feedback from industry stakeholders on the rationale, timing and potential impact of the charge adjustment, which the TGA says is intended to support regulatory activities.

Interested parties are invited to submit their comments by the deadline specified in the consultation notice, after which the TGA will decide whether to implement the temporary fee change.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Asia-Pacific Roundup: TGA seeks feedback on temporary increase to Australia’s annual device charges”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 21h agoRecon: FDA approves Edwards’ tricuspid valve repair device; Bayer wins Chinese approval for blood thinner asundexianraps
  • 3d agoThis Week at FDA: Peptide dispute, clinical trial legislation, and moreraps
  • 3d agoExperts call for culture change, standards to fulfill the promise of RWEraps
  • 4d agoEuro Roundup: EMA seeks feedback on platform trials; MHRA to recognize CE-marked devices indefinitelyraps
  • 4d agoFDA warns Baxter, Olympus for GMP and QSR violationsraps